KAIST 생명과학과동창회
  • News & Events
  • News

News

Antibiotic tolerance study paves way for new treatments


A new study identifies a mechanism that makes bacteria tolerant to penicillin and related antibiotics, findings that could lead to new therapies that boost the effectiveness of these treatments.


Antibiotic tolerance is the ability of bacteria to survive exposure to antibiotics, in contrast to antibiotic resistance, when bacteria actually grow in the presence of antibiotics. Tolerant bacteria can lead to infections that persist after treatment and may develop into resistance over time.

The study in mice, “A Multifaceted Cellular Damage Repair and Prevention Pathway Promotes High Level Tolerance to Beta-lactam Antibiotics,” published Feb. 3 in the journal EMBO Reports, reveals how tolerance occurs, thanks to a system that mitigates iron toxicity in bacteria that have been exposed to penicillin.


“We’re hoping we can design a drug or develop antibiotic adjuvants that would then basically kill off these tolerant cells,” said senior author Tobias Dörr, assistant professor of microbiology in the Weill Institute for Cell and Molecular Biology in the College of Agriculture and Life Sciences.


Co-authors included Ilana Brito, the Mong Family Sesquicentennial Faculty Scholar and assistant professor in the Meinig School of Biomedical Engineering in the College of Engineering, and Lars Westblade, associate professor of pathology and laboratory medicine at Weill Cornell Medicine.


Some bacteria, including the model bacterium used in the study, Vibrio cholerae, which causes cholera in humans, are remarkably tolerant to penicillin and related antibiotics, known as beta lactam antibiotics. It has been known for a long time that beta-lactam antibiotics break down bacterial cell walls, but how bacteria survive loss of their cell walls was poorly understood.


In the study, the researchers developed a V. cholerae mutant that lacked a two-component damage repair response system that controls a gene network encoding diverse functions. Without the system, known as VxrAB, when the cell wall is damaged by antibiotics, the transfer of electrons across the cell membrane goes awry, leading to electrons ending up on the wrong molecules. This misdirection causes hydrogen peroxide to accumulate in the cell, which changes the oxidation state of cellular iron and disrupts signals for the cell to tell how much iron it has.   


In the presence of hydrogen peroxide, the mutant bacteria cannot sense how much iron has been acquired, and it behaves as if it is iron-starved and seeks to acquire more iron. Left unchecked, these circumstances cause iron toxicity, which will kill the cell, according to the experiments the researchers conducted. In further tests with mutant V. cholerae bacteria, both in test tubes and in mice, the researchers showed that reducing the influx of iron increased the bacteria’s tolerance to beta lactams.


Fortunately for normal V. cholerae, exposure to antibiotics and the breakdown of the cell’s walls activate the VxrAB system, which works to repair cell walls and downregulates iron uptake systems, and thereby creates antibiotic tolerance. More study is needed to understand what triggers the VxrAB system in the presence of beta-lactam antibiotics.


The research opens the door for developing new drugs that could be combined with antibiotics to exploit oxidative damage and iron influx in tolerant bacteria. In future work, the researchers will search for parallel mechanisms of tolerance in other bacterial pathogens.


Jung-Ho Shin, a postdoctoral researcher in Dörr’s lab, is the paper’s first author. Co-authors include researchers from the Korea Advanced Institute of Science and Technology, the Korea Advanced Institute of Science and Technology, and the Intelligent Synthetic Biology Center in Korea.

The study was funded by the National Research Foundation of Korea and the National Institutes of Health.


https://news.cornell.edu/stories/2021/02/antibiotic-tolerance-study-paves-way-new-treatments

https://www.miragenews.com/antibiotic-tolerance-study-paves-way-for-new-516267/



List of Articles
번호 제목 글쓴이 날짜 조회 수
130 김은준 서연수 교수 우수교원 포상 과사무실 2004.02.13 13209
129 송세라, 박영균 학생 김보정 기초과학장학생으로 선발 과사무실 2006.09.12 13215
128 김근화 박사, 김승균 박사, 박상욱 박사, 2012년도 이공분야 '학문후속세대양성사업' 선정 과사무실 2013.01.02 13294
127 김세원 박사과정(강창원 교수 lab), Santorini Best Poster Award 수상! 과사무실 2011.06.17 13306
126 생명과학과 권창섭 연구교수... Trends in Genetics지 논문 게재 과사무실 2007.08.20 13309
125 최은비 박사과정 학생(김미영 교수 실험실) Oncogene 게재(2016.02) / Eun-Bee Choi, a Ph.D candidate in Prof. Mi-Young Kim’s lab published a paper in Oncogene (2016.02) 생명과학과 2016.03.07 13309
124 김학성 교수, Nature Communications 게재 (2014. 4) 과사무실 2014.04.24 13342
123 [경향신문] 뇌에서 시냅스 생성촉진 새 단백질 발견 -김은준교수팀 과사무실 2006.09.18 13345
122 김선창 교수 6월의 과학기술자 선정 과사무실 2003.09.08 13348
121 변시명 교수 기초과학 교과목 우수강의상 수상 1 과사무실 2004.03.17 13350
120 [동아일보] 위암 당뇨 ‘맞춤 치료’ 길 열린다…SNP 지도 첫 완성 과사무실 2006.12.14 13357
119 허원도 교수, Mai Khanh Nguyen 박사과정 학생 Nature Chemical Biology 논문 게재(2016.04) / Prof. Won Do Heo and Mai Khanh Nguyen Ph.D. published a paper in a Nature Chemical Biology(2016.04) 생명과학과 2016.04.12 13357
118 최광욱 교수, 2014 국내 바이오분야 연구성과 및 뉴스 Top5 선정 / Prof. Kwang-Wook Choi was selected as Top 5 news of 2014 in domestic bio research field 과사무실 2015.01.15 13379
117 고규영 교수님 Circulation Research 논문 COVER게재 과사무실 2007.03.21 13383
116 이준식 교수 IAFOST Fellow 선출 과사무실 2003.09.08 13390
115 최길주 교수, 정진길 박사 Nature Communications지 논문 게재 (2014. 8) 과사무실 2014.09.11 13445
114 이규리 학생(박태관 교수님 Lab), ICMAT 2009 & IUMRS-ICA 2009 Best Poster Award 수상 과사무실 2009.07.13 13453
113 [중앙일보] 생명과학과 박지혜 '로레알 여성생명과학상' 수상 과사무실 2006.06.22 13457
112 최준호 교수, '이달의 과학기술자상' 수상 과사무실 2011.12.01 13472
111 김재섭 교수 논문 Nature Genetics 게재 과사무실 2005.01.31 13507
Board Pagination Prev 1 ... 11 12 13 14 15 16 17 18 19 20 ... 22 Next
/ 22